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Abstract

Each day, antibiotic resistance affects the livelihood of individuals worldwide, especially
in relation to hospital-acquired diseases. In an effort to combat this resistance, antimicrobial
peptides, small biopolymers produced naturally by multicellular organisms, can be used to
selectively eliminate bacteria and have demonstrated great potential as alternatives to
conventional antibiotics. Many naturally-occurring antimicrobial peptides possess high
concentrations of lysine and arginine amino acid residues, which are protonated and positivelycharged at physiological pH. Herein, we describe the design and synthesis of antimicrobial
peptide mimics, using amino acid mimics. N-3-aminopropyl methacrylamide (APMA) and 3guanidinopropyl methacrylamide (GPMA) monomers mimic the amino acid residues lysine and
arginine, respectively. Statistical copolymers of these two monomers were synthesized via
aqueous reversible addition-fragmentation chain transfer (RAFT) polymerization and exhibited
antimicrobial activity and low eukaryotic cell toxicity. To further analyze the mode of activity of
these antimicrobial peptide mimics, large unilamellar vesicles (LUVs) containing fluorescent dye
were prepared in an attempt to study the mechanisms of copolymer interactions with bacteria. .
Developing a greater understanding of the relationship between the structure of synthetic
antimicrobial peptide mimics and their respective mode of antimicrobial activity will aid in the
design of tailored systems to target specific bacterial species.

Keywords: Antibiotic resistance; antimicrobial peptide mimics; polymers
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Chapter I: Introduction

1.1 Prevalence of Antibiotic-Resistant Organisms

Over the past several decades, the increasing number of microorganisms resistant to
traditional antibiotics has caused a growing concern for the well-being of individuals worldwide.
A few examples of resistant bacteria include methicillin-resistant Staphylococcus aureus
(MRSA), Streptococcus pneumoniae, and multidrug-resistant tuberculosis (MDR TB). The
presence of resistant strains of bacteria leads to increased healthcare costs for possible treatments
and an increase in the mortality rate of infected individuals. The amount of drug resistance can
be attributed, at least in part, to the overuse of widely-available traditional antibiotics, which
inadvertently promotes the presence of resistant pathogens and adaptive mutations.1 In an effort
to circumvent these and other severe bacterial infections, researchers have sought to exploit the
benefits of naturally-occurring, antimicrobial peptides.2-6

23456
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Antimicrobial peptides (AMPs) are biological polymers, typically 20 to 50 amino acids in
length, found in a variety of multicellular organisms. AMPs selectively target bacterial cells and
induce cell death without causing harm to eukaryotic cells within a certain therapeutic
concentration range.7 Because of the high concentrations of basic amino acids, such as lysine and
arginine, found in these peptides, AMPs are generally positively-charged at physiological pH
(Figure 1). Initial interactions between AMPs and bacteria are facilitated via electrostatic
attraction due to the abundance of negatively-charged phospholipids in the cytoplasmic
membrane of bacteria. In addition to these hydrophilic residues, AMPs also possess hydrophobic
regions that can be inserted into the hydrophobic core of the membrane and induce cell death by
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way of membrane disruption. In order for bacteria to develop resistance to these peptides, a
drastic change in the bacterial cell membrane would have to occur.7

Figure 1. Structures of cationic amino acids lysine (A) and arginine (B), which are protonated at
physiological pH (~7.4).

Although bacteria share similar structural features, varying membrane compositions can
lead to differences in therapeutic susceptibility. Thus, certain bacterial species may be vulnerable
only to particular AMPs or synthetic derivatives.8 Differences in vulnerability could be the result
of the various modes in which the therapeutic agents induce cell death. Unfortunately, the
mechanisms driving the activity of AMPs are quite complex and not fully understood due to the
plethora of AMP structures, host biological composition, and other not-well defined variables.7
This research project aims to develop a better understanding of the factors that may affect the
antimicrobial activity of AMPs by designing structures that mimic naturally, occurring AMPs
and analyzing the respective modes of activity of these systems.

2

Chapter II: Literature Review of Antimicrobial Peptides and Synthetic Mimics

2.1 Antimicrobial Peptides

Antimicrobial peptides (AMPs) exhibit selective targeting and elimination of bacterial
species over eukaryotic tissues. The preferred selection of prokaryotes is governed by
electrostatic attraction between AMPs and bacterial cytoplasmic membranes at physiological pH
(~7.4 ).7 AMPs possess high concentrations of the basic amino acids lysine and arginine, which
are protonated and positively-charged at physiological pH. The outermost leaflet of prokaryotic
cytoplasmic membranes is composed of negatively-charged phospholipid head groups, such as
phosphatidylglycerol, cardiolipin, and phosphatidylserine.8 The electrostatic interactions between
positively-charged AMPs and negatively-charged prokaryotic cell membranes mediate the initial,
rapid targeting of the bacterial species. The speed at which this interaction occurs must be
relatively fast in order to avoid renal excretion of the AMPs.9 Eukaryotic cell membranes, on the
other hand, are populated with a majority of zwitterionic phospholipids, such as
phosphatidylethanolamine, phosphatidylcholine, and sphingomyelin. Since they exhibit a net
neutral charge, eukaryotic cells are less likely to be targeted by AMPs due to the limited
electrostatic attraction.8 Cholesterol found in the lipid bilayer of eukaryotic membranes is also
believed to either enhance the stability of the bilayer to AMP infiltration or aid in the
deactivation of the AMP molecule before membrane disruption can occur.10
AMPs consist of approximately 50% hydrophobic residues, and their hydrophobic
character is essential for inducing cell death. After the peptide is attracted to a phospholipid
membrane, the hydrophobic portion of the peptide enters the hydrophobic core, causing the
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integrity of the membrane to be compromised.11 A schematic representation of one accepted
mechanism for this process, known as membrane disruption, is depicted in Figure 2. Studies12-4
have shown that the selectivity of antimicrobial polymers towards prokaryotic cells over
eukaryotic cells decreases with increases in available hydrophobic interactions. Thus, if the
hydrophobicity of the compound is increased past a critical concentration, mammalian cell death
will dramatically increase despite the presence of zwitterionic phospholipids and other
compounds in the membrane. These studies12-4 suggest that an amphipathic balance of
hydrophilicity and hydrophobicity must be maintained to minimize eukaryotic cell toxicity while
maximizing antimicrobial efficiency.

Figure 2. The barrel-stave model of the AMPs biocidal mechanism. Modified from Brogden et
al.13 and extracted from Paslay et al.14
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An alternative proposed mechanism of antimicrobial action involves AMPs permeation
of the cell membrane of bacteria and binding to the negatively-charged nucleic acids in the cell,
which leads to the inhibition of protein synthesis.15 Because AMPs interact with the phospholipid
bilayer of the cytoplasmic membrane, bacterial cells are less likely to develop resistance to
AMPs than to other conventional antibiotics that may only inhibit pathways that can develop
resistance easily through mutations.8 A drastic change to the membrane composition is highly
unlikely, which contributes to the difficulty in developing resistance.8 However, a limited
number of organisms have been shown to develop resistance to naturally-occurring AMPs by
altering the net charge of their outer surface, manipulating the proteins found in the membrane,
and expressing genes for the production of proteolytic enzymes to degrade AMPs.13
Despite the specificity and therapeutic advantages of AMPs over conventional
antibiotics, there are several disadvantages of using AMPs. Even though various multi-cellular
organisms produce AMPs naturally, extraction procedures typically exhibit low yield.
Furthermore, AMPs can be synthesized from individual amino acids; however, the production
and purification costs for these compounds are quite high.10

2.2 Synthetic Antimicrobial Peptide Mimics

To compensate for the relatively low abundance and costly direct synthesis of AMPs,
researchers have since attempted to find alternative routes of creating AMP mimics using
synthetic methods.

5

Figure 3. A variation of polynorbornene derivatives with differences in hydrophobicity to mimic
AMPs.4
Utilizing ring opening metathesis polymerization (ROMP) with polynorbornene
derivatives, Ilker et al.4 sought to mimic AMPs by forming homopolymers containing a pendant
primary amine, characteristic of the amino acid lysine, shown in Figure 3. The protonated form
of this pendant moiety mediates the binding of the polymers to the anionic phospholipid-rich
surface of prokaryotic cells. Variation in relative hydrophobicity was obtained by changing the
alkyl chain length and structure as shown in Figure 3 A-D. Antimicrobial studies showed
polymer A, which had the least amount of hydrophobic character, was ineffective at eliminating
bacteria. By increasing the hydrophobicity of the polymers, a general trend of increased
antimicrobial activity and decreased selectivity was observed. Thus, Ilker and coworkers were
able to manipulate the amphiphilic balance of the polymers using monomers with desired
properties at various ratios to synthesize statistical copolymers.4 These polymers were found to
induce prokaryotic cell death via a membrane disruption mechanism. The initial binding to the
prokaryote was believed to be facilitated by the electrostatic interactions between the cationic
polymers and the anionic phospholipid bilayer of bacterial membranes. The hydrophobic regions
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of the polymers interacted with the hydrophobic core of the phospholipid bilayer, causing the
cell to rupture.

Figure 4. Varying the degree of lipophilic character on the pendant amine moiety for statistical
copolymers.14
In previous studies in our laboratories (Paslay et al.14), we designed statistical copolymers
via aqueous reversible addition-fragmentation chain-transfer (RAFT) polymerization using
monomers with lysine-mimicking residues. The relative hydrophobic character of the monomers
was altered by incorporating two methyl and two ethyl groups, respectively, as part of the
pendant amine, as shown in Figure 4. Paslay et al. hypothesized that increasing the
hydrophobicity would increase membrane activity towards bacteria, while the fully water-soluble
nature of the amine species would reduce eukaryotic cell toxicity. While all the polymers
displayed minimal eukaryotic toxicity, copolymers containing high concentrations of primary
amine showed the highest levels of toxicity to both Gram-positive and Gram-negative bacteria.14
Gabriel et al.3 explored the possibility of incorporating a guanidinium moiety to alter the
mode of cell death. The primary amine of polymer A, shown in Figure 3, was substituted with a
guanidinium moiety, shown in Figure 5A, which mimics the amino acid arginine.3 Peptides rich
in arginine have been shown to present cell penetrating behavior. There has been much research
exploring various mechanisms in which these arginine-rich peptides are internalized by a cell.16
7

Upon internalization, this type of peptide has been shown to bind to negatively-charged nucleic
acids and inhibit protein synthesis. These and other disruptions in cellular processes promote the
inability of the cell to sustain life.15 While polymer A was ineffective in killing bacteria, upon the
replacement of the primary amine with the guanidinium moiety for polymer A, Gabriel and
coworkers showed that the polymer had selective antimicrobial activity without causing any
observable prokaryotic membrane disruption.3

Figure 5. Polymer A4 (from Figure 3) substituted with a guanidinium moiety (A).3 Polymer C4
(from Figure 3) modified with variations in charge density (B).2

Al-Badri et al.2 evaluated the effect of charge density on selectivity for synthetic AMP
polynorbornene derivatives. Polymer C, shown in Figure 3, was modified by increasing the
number of pendant primary amines from 1 to 3, as shown in Figure 5B. These systems showed a
decrease in the hemolytic concentration (HC50), or the minimum concentration required for 50%
hemolysis of blood cells, changing from very hemolytic to (<1 μg/mL) to much less hemolytic
(700 μg/mL). This suggests an increase in biocompatibility results with increased charge density
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while maintaining the same relative antimicrobial efficiency reported for the original polymer.
Further studies are needed to determine if there is a maximum amount of charge density where
no improved selectivity would be observed.

Figure 6. Structure of HPMA-b-GPMA block copolymer. Extracted from Treat et al.17

In a recent communication, Treat et al.17 report the synthesis of guanidinium-containing
polymers via aqueous RAFT polymerization to mimic cell-penetrating peptides (Figure 6). 3guanidinopropyl methacrylamide (GPMA) was copolymerized with N-(2-hydroxypropyl)
methacrylamide (HPMA) to create block copolymers. The penetration of these polymers into
KB cancer cells through endocytosis and non-endocytosis pathways was probed. Only the
polymers containing the guanidinium moiety in this study were shown to penetrate the cell
membrane. Polymers deficient in the guanidinium moiety did not penetrate the cell membrane.
Antimicrobial activity and biocompatibility were not analyzed in this study.
The cell penetration behavior of AMPs mimics and the mechanism by which cell death is
induced are not well understood. Because of the variable nature of bacterial species, prokaryotes
do not all possess the same cell membrane composition, overall charge, expressed genes, and
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many other characteristics. We hypothesize that structural variations in synthetic AMPs mimics,
including charge density, molecular weight, hydrophobicity, and functional groups, have a direct
relationship to antimicrobial activity towards bacteria of different structures. Developing a
greater understanding of the relationship between AMPs structure and antimicrobial activity for
bacterial species of different types will ultimately enable the design of systems to target specific
prokaryotes based upon their structural features.

Chapter III: Methodology

3.1 Research Goals and Objectives

The purpose of this research is to design novel homopolymers and statistical copolymers
that mimic antimicrobial peptides and to study their antimicrobial behavior in order to gain a
better understanding of the relationship between structural components and mode of activity. The
goals of this project can be outlined by three main objectives:
1) Evaluation of antimicrobial activity and hemolytic character of synthesized polymers
to determine the relationship between activity and polymer composition.
2) Determination of the relationship between structural features of synthesized
polymers, such as molecular weight and ionic character, and mechanism of activity.
3) Characterization of the selectivity of various homopolymer and copolymer systems
towards a broad range of cell types, including Gram-positive bacteria, Gram-negative
bacteria, red blood cells, and other complex eukaryotic cells.
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3.2 Synthesis and Characterization of Antimicrobial Peptide Mimics

Two monomers, N-3-aminopropyl methacrylamide (APMA) and 3-guanidinopropyl
methacrylamide (GPMA), were used to create homopolymers and statistical copolymers of
varying copolymer compositions (Table 1). The nomenclature PGT represents polyGPMA TFA
and the corresponding number indicates its targeted mole fraction (mol %) in the copolymer. For
example PGT 25 represents a copolymer composed of 25 mol % GPMA TFA and 75 mol %
APMA. The nomenclature Cl and TFA next to the polymer represent the counterion for APMA
and GPMA, respectively.

Table 1. Target molecular weight and copolymer composition data for proposed polymer
systems.
Polymer Label
1 (PAPMA) (Cl)
2 (PGT 25) (TFA)
3 (PGT 50) (TFA)
4 (PGT 75) (TFA)
5 (PGT 100) (TFA)

Mol % GPMA
(theory)
0
25
50
75
100

Mol % APMA
(theory)
100
75
50
25
0

Mn (g/mol)
5,600
6,500
7,400
8,300
9,200

APMA consists of a pendant primary amine moiety, similar to the amino acid lysine, and
was commercially available. GPMA consists of a pendant guanidinium moiety, similar to the
amino acid arginine (Figure 7).
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Figure 7. Structures of N-3-aminopropyl methacrylamide (APMA) and 3-guanidinopropyl
methacrylamide (GPMA).

Since GPMA is not commercially available, this monomer was synthesized (Scheme 1).
In a 250 mL round bottom flask, APMA HCl was dissolved in a mixture of 12 mL DI H2O and
20 mL (148 mmol) TEA and stirred at 25°C. 10 g (32 mmol) N,N’-di-boc-1H-pyrazole-1carboxamidine (PCA) was dissolved in 108 mL acetonitrile and added dropwise to the stirring
APMA solution via an addition funnel over the course of 30 min. The reaction progressed for 24
hours. The product was obtained via filtration and then washed 3 times with 50 mL DI water
(yield = 91%).
In a 250 mL round bottom flask, 10.96 g (28.48 mmol) boc-protected GPMA was
dissolved in 87 mL CH2Cl2 stirring at 0°C. 87 mL (1.14 mol) (20 equivalences per bocprotecting group) trifluoroacetic acid (TFA) was then added to the solution dropwise via an
addition funnel and the reaction was allowed to progress for 16 hours warming from 0°C to
25°C. The solvents were removed via rotary evaporation and the resulting clear viscous oil was
dissolved in 250 mL DI H2O, frozen in liquid N2 and lyophilized for 48 hours. The product was
obtained as a white solid.
12

Scheme 1. Synthesis of GPMA with TFA salt.
The polymerizations were accomplished via aqueous reversible addition chain transfer
fragmentation (RAFT) techniques. Polymer molecular weights were targeted by selecting
appropriate initial monomer and CTA concentrations. The ratio of the initial monomer
concentration (M0) to the initial chain transfer agent concentration (CTA0) was set to be
approximately 30:1 to yield a degree of polymerization of approximately 30, which mimics the
size of naturally occurring AMPs. 4-cyano-4-(ethylsulfanylthiocarbonylsulfanyl)pentanoic acid
(CEP) was used as the CTA and was synthesized via previously published procedures,18 while
4,4’-Azobis(4-cyanopentanoic acid) was used as the initiator. For all polymerizations, the CTA0
was five times more than the initial initiator concentration (I0). The polymerization took place in
aqueous 2 M acetate buffer (pH 5) at 70 °C19 for 6 hours (See Scheme 2). Methanol was added
in low quantities (20%) to improve the solubility of CEP in the aqueous media. After the
13

reactions were completed the solutions were exposed to air and quenched in liquid nitrogen. The
solutions were then dialyzed against water for 72 hours followed by lyophilization for 72 hours
and the samples were then stored in desiccant. A representative yield was calculated to be 75%
of the theoretical yield. Some polymer is lost in dialysis due to excessive swelling of the dialysis
tubing as a result of internal osmotic pressure. This loss can be minimized by making the water
slightly acidic during the dialysis procedure to reduce the extent of swelling.

Scheme 2. Statistical polymerization of APMA with GPMA via aqueous RAFT polymerization.

3.2.1 Nuclear Magnetic Resonance (NMR) Spectroscopy

Proton (1H) NMR was performed with a Varian MercuryPLUS 300 MHz spectrometer in
deuterated chloroform (CDCl3), utilizing delay times of 5 s to determine monomer purity. A 500
MHz NMR equipped with a standard 5 mm proton and carbon-13 (1H/13C) probe and operating
at 499.77 MHz (1H) was used to confirm the synthesis of the GPMA monomer, identify the
homopolymer structures of PAPMA and PGT 100, and identify the statistical structures of PGT
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25, PGT 50, and PGT 75 copolymers in deuterium oxide (D2O). 64 scans were taken for each
experiment with a 3.1 second recycle delay.

3.2.2 Aqueous Size Exclusion Chromatography

The molecular weight and polydispersity index (PDI) of the polymers were determined
by aqueous size exclusion chromatography (ASEC) coupled with multi-angle laser light
scattering (MALLS). Eprogen CATSEC columns (100, 300 and 1000 Å) were used in
combination with a Wyatt Optilab DSP interferometric refractometer (k = 690 nm) and a Wyatt
DAWN DSP MALLS detector (k = 633 nm). Acetic acid (1 weight %) and 0.1 M sodium
sulfate (Na2SO4) (aqueous) was used as the eluent at a flow rate of 0.25 mL/min. The
interferometric refractometer was utilized off-line to determine dn/dc values for PAPMA at 25
°C in the eluent (0.2000 mL/g) in order to assign absolute molecular weight values to all
polymers. For the statistical polymers the dn/dc values were calculated as the mole fractionaveraged composites of the measured homopolymer dn/dc values using the copolymer
compositions determined by NMR spectroscopy. Wyatt ASTRA size exclusion
chromatography/light scattering (SEC/LS) software was used for molecular weight and PDI
calculations.
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3.3 Quantification of Antimicrobial Activity

3.3.1 Broth Microdilution Method

Antimicrobial efficiency of the polymers was assessed using Bacillus subtilis (19659),
Staphylococcus aureus (both Gram-positive bacteria), and Escherichia coli (DH5 α) (Gramnegative bacteria) following a modified version of a previously published procedure.3 Stock
solutions of both bacterial species were grown at 37°C in inoculated Luria broths (LB) overnight
while undergoing agitation. Concentrations of 4 to 6 mg/mL polymer stock solutions were
prepared in tris(hydroxymethyl)aminomethane (TRIS) buffered saline (TBS) (10 mM TRIS, 150
mM NaCl) (pH 7.4). In a 96 well plate, varying buffered polymer dilutions were mixed 1:1 with
bacterial cultures that have been diluted with fresh LB to an optical density (OD) of 0.001 at 600
nm (OD600). Over a 24-hour period, these mixtures were incubated at 37°C with agitation. The
OD600 was determined using to a UV-Visible plate reader after incubations. Minimum inhibitory
concentrations (MIC) were reported at multiple time intervals as the polymer concentrations that
inhibit 90% of bacterial growth.

3.3.2 Agar Plate Conformation of MIC

To confirm the MIC measurements from the broth microdilution experiments, the
polymer concentrations above and below the MIC were inoculated with the respective bacterial
species (B. subtilis, S. aureus, or E. coli) for 24 hours at 37°C with agitation. Inoculums were
streaked onto sterile LB agar plates and incubated for an additional 18 hours at 37°C to allow for
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any prevailing bacterial growth. If any living bacteria remained after incubation, bacterial
colonies were visible on the agar plates. The absence of bacterial growth at the respective
polymer concentrations confirmed the previously determined MIC.

3.4 Assessment of Eukaryotic Biocompatibility

3.4.1 Hemolysis Studies

Hemolysis experiments were performed according to a modified version of a previously
published procedure.4 Red blood cells (RBCs) were separated from whole human blood by
centrifugation at 1500 rpm for 10 minutes. RBCs (30 μL) were suspended in 10 mL of buffer
(TBS at a pH of 7.4), rinsed 3 times by centrifugation (10 min at 1500 rpm) and then resuspended in 10 mL TBS. Polymers were dissolved in TBS to create 6.0 mg/mL stock solutions.
These solutions were diluted to 0.1, 0.2, 2.0, 4.0 and 6.0 mg/mL. RBC suspensions were
incubated 1:1 at 37 °C with light agitation for 30 min with polymer dilutions in microcentrifuge
tubes to obtain final polymer concentrations of 0.05, 0.1, 1.0, 2.0 and 3.0 mg/mL. After
incubation, the tubes were centrifuged at 1500 rpm for 10 min. The supernatant from each tube
was transferred to individual wells in a 96 well plate and the absorbance was measured at 540
nm. Positive and negative controls for 100 and 0% hemolysis were obtained with 1% Triton-X
and TBS, respectively.
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3.4.2 MTT Assay (Cell Viability)

Methyl thiazol tetrazolium (MTT) assay were performed with MCF-7 cell lines using a
modified version of a previously published procedure.20 Cells were cultured on tissue culture
polystyrene flacon flasks in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with
10% fetal calf serum and 1% antibiotic solution (penicillin and streptomycin) at 37 °C in a 5%
CO2 incubator. After obtaining approximately 80% confluence the cells were trypsinized and
counted on a hemocytometer. The cells in fresh media were placed into a 96 well plate (8x103
cells/well) and incubated for 24 hours at 37 °C in a 5% CO2 incubator. Next, the media was
removed from each well and 100 μL of fresh media was added. To select wells (in triplicate) 50
μL of polymer solutions were added at various concentrations (90, 225, 375, and 6000 μg/mL).
The resulting solutions had final polymer concentrations of 30, 75, 125, and 2000 μg/mL,
respectively. For a positive control, 50 μL TBS (pH 7.4) was used, while 50 μL 3% Triton-X
was used as a negative control. Reported data was normalized for viability observed in the
positive control (taken as 100% viability). The plate was incubated for 6 or 12 hours at 37 °C in
a 5% CO2 incubator. After incubation, the media was removed from each well and 100 μL of
fresh media was added. Next, 10 μL of MTT reagent (MTT dissolved in TBS at 5 mg/mL
concentration) was added to each well and samples were incubated for an additional 4 hours.
The media from each well was then removed and replaced with 100 μL of DMSO to solubilize
the formed formazan crystals. Absorbance readings at 570 nm were recorded using a UVVisible plate reader.
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3.5 Determination of Prevailing Mode of Activity

Large unilamellar vesicles (LUVs) were prepared according to a modified version of a
previously published procedure to determine mode of polymer activity.3 A solution of
zwitterionic lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-ethanolamine (POPE) (3.42 mg,
0.0045 mmol) and the anionic lipids 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) (1.15
mg, 0.0015 mmol) were mixed in a 3:1 ratio with 10 mL of chloroform in a 50 mL round-bottom
flask, mimicking the composition of bacterial cell membranes. The solvent was removed at room
temperature using a rotary evaporator to form a uniform film in the round-bottom flask. To
remove any residual solvent, the flask was placed under vacuum for an additional 8 hours. A 40
mM calcein solution (aqueous) was prepared using a buffer (TBS at a pH of 7.4) as the solvent.
The calcein dye solution was adjusted to an approximate pH of 7. The dry lipid film was then
hydrated with 1.5 mL of the 40 mM calcein solution. The lipid and calcein mixture was
subjected to five freeze/thaw cycles (5 minutes each) using liquid nitrogen and warm water,
consecutively. Two stacked 200 nm porous polycarbonate membranes were heated to 40°C
before the entire volume of the mixture was subjected to extrusion for a total of 20 passes
(Figure 8). The mixture was then removed from the extrusion apparatus and allowed to
equilibrate to room temperature before being passed through a Sephadex-25 column to remove
residual calcein dye. Fractions of approximately 5 drops each were collected in Eppendorf
microcentrifuge tubes. The vesicle solutions were stored at 4°C and diluted as needed for up to 4
days.
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Figure 8. Avanti Polar Lipids, Inc. Mini-Extruder was used to form uniform vesicles with a 200
nm hydrodynamic radius.21

After the collection of the fractions, the hydrodynamic radius of the artificial vesicles was
analyzed and confirmed to be 200 nm using dynamic light scattering. UV-Vis spectroscopy was
used to determine the proper vesicle concentration to use for the LUV experiments. For this, 0.4
weight % Triton-X was added to the vesicle solution and the vesicle dilution for which the
absorbance was less than 0.01 absorbance units for the UV-Vis experiment was recorded and
used for the subsequent LUV studies. The average MIC of polymers (70 µg/mL) was used as the
respective polymer concentration for the LUV studies. The percentage dye leakage was recorded
as a function of time with a fluorometer after allowing 1 minute for the system to equilibrate per
sample. The amount of dye released from the LUVs was evaluated to determine the mechanism
of cell death, with a large release amount indicating cell death via a membrane disruption
mechanism, while a small release amount indicates a membrane penetration mechanism of action
of the polymers.
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Chapter IV: Results and Discussion

4.1 Monomer and Polymer Characterization

As described in detail previously, the NMR spectra were collected for the boc-protected GPMA
(Figure 9) and the final boc-deprotected GPMA salt (Figure 10). Most notable in Figure 9 is the
presence of the tert-butyl ester protecting group (~1.5 ppm) from the reaction with PCA. Upon
deprotection with TFA, the signal peak at ~1.5 ppm disappears and the amine protons of the guanidinium
moiety become noticeably present from ~7.0 to 8.0 ppm in Figure 10.

Figure 9. 1H NMR spectrum of boc-protected GPMA.

21

Figure 10. 1H NMR spectrum of GPMA after boc-deprotection with TFA.

During the aqueous RAFT polymerization process, the reaction progress of APMA-statGPMA was monitored by taking aliquots every hour from the PGT 50 reaction vial. 1H NMR
was utilized to determine the monomer concentration [M] at time (t) by comparing the vinylic
hydrogen peak integrations to the integration of an internal standard, methanol (MeOH). A plot
of ln([M0]/[M]) versus time indicates that the reaction follows linear pseudo first-order reaction
kinetics (Figure 11).
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Figure 11. APMA-stat-GPMA reaction kinetics. ln([M0]/[M]) versus time kinetic plot for the
polymerization of 1:1 molar ratio of APMA:GPMA TFA. The linear relationship indicates that
the polymerization follows a predictable first-order reaction behavior typical of aqueous RAFT
polymerizations.

Aqueous size exclusion chromatography (ASEC) coupled with multi-angle laser light
scattering (MALLS) was utilized to monitor molecular weight as a function of time. The
refractive index (RI) response versus elution volume for aliquots taken at each time interval is
shown in Figure 13. As shown in this graph, the polymer molecular weight increases over time.
The narrowing of the peak is indicative of a narrowing PDI over time.

23

RI Response

1 hr
2 hr
3 hr
4 hr
5 hr

8

8.5

9
9.5
Elution Volume (mL)

10

10.5

Figure 12. APMA-stat-GPMA molecular weight distribution as a function of reaction time. RI
response versus elution volume at multiple time intervals during the polymerization reaction.

For each of the polymers, unique peak assignments were made, and the copolymer
compositions were calculated for the statistical polymers via peak integration (Figure 13). A
summary of molecular weight characterization data is provided in Table 2.
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Figure 13. Representative 1H NMR spectrum of APMA-stat-GPMA copolymer. The target
APMA/GPMA composition for the above formulation was 50:50 mol %. Peak integration
indicates 45 mol % GPMA in the copolymer.

Table 2. Summary of molecular weight and composition data for synthesized homopolymers and
copolymers.

Polymer Label
1 (PAPMA) (Cl)
2 (PGT 25) (TFA)
3 (PGT 50) (TFA)
4 (PGT 75) (TFA)

Mol %
GPMA
(theory)
0
25
50
75

Mol %
GPMA
(exp)a
0
23
45
72

Mn,th
(g/mol)b

Mn,exp
(g/mol)c

PDIc

dn/dcd

5,600
6,500
7,400
8,300

6,500
6,900
6,100
5,800

1.06
1.03
1.06
1.12

0.200
0.183
0.169
0.152

5 (PGT 100) (TFA)
100
100
9,200
8,100
1.04 0.132
1
b
c
Determined by H NMR. Based on 90% conversion of [M0]. Determined by ASECMALLS. dDetermined by a Wyatt Optilab DSP interferometric refractometer.
a
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4.2 Antimicrobial Behavior

The minimum inhibitory concentrations (MIC) were determined for each polymer for
each of the three bacteria types (B. subtilis, S. aureus, and E. coli). The findings of these
experiments are summarized in Table 3.

Table 3. Summary of broth microdilution testing of various polymers with bacteria as
determined through optical density measurements.
Minimum Inhibitory Concentration (MIC) (µg/mL)a
B. subtilisb
Polymer Label
S. aureusb E. coli (DH5 α)c
(19659)
1 (PAPMA) (Cl)
< 25
~ 300
≥ 300
2 (PGT 25) (TFA)
< 25
~ 300
70 - 300
3 (PGT 50) (TFA)
< 25
~ 300
70 - 300
4 (PGT 75) (TFA)
< 25
~ 300
~ 70
5 (PGT 100) (TFA)
< 25
~ 300
~ 70
a
Determined by broth microdilution testing.
b
Gram (+) bacteria. cGram (-) bacteria.

To validate the MIC measurements obtained from the broth microdilution testing, the
polymer concentrations above and below the MIC were inoculated with the respective bacterial
species (B. subtilis, S. aureus, or E. coli), streaked onto agar plates and allowed to grow. As
shown in Figure 14, the inoculums grown on the agar plates confirmed the MIC values obtained
from the broth microdilution testing.
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PAPMA

PGT 50

PAPMA

PGT 25

PGT 75

PGT 50

PGT 100

PGT 75

PGT 100

(i) B. subtilis

PAPMA

PGT 25

(ii) S. aureus

PGT 25

Figure 14. MIC agar plate confirmation. All
agar plates consisted of a negative control (-)
where only bacteria and no polymers were
present along with a positive control (+) where
only polymers and no bacteria were present. (i)
B. subtilis with polymer concentration ranges of
25 (B), 50 (C), 70 (D), and 80 (E) µg/mL. (ii) S.

PGT 50

PGT
75

aureus with polymer concentration ranges of 70
(A), 150 (B), 230 (C), and 300 (D) µg/mL. (iii)
E. coli with polymer concentration ranges of 70

(iii) E. coli

PGT
100

(A), 150 (B), 230 (C), and 300 (D) µg/mL.
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4.3 Hemolysis Studies

An effective way to test eukaryotic cell toxicity is to study the hemolytic behavior of a
system. While not conclusive, hemolysis experiments are used to indicate the possibility of
eukaryotic cell toxicity. Less than 10 % hemolysis was observed for all polymer types, even at
high concentrations (3,000 µg/mL). With increasing polymer concentration the percentage of red
blood cells that lyse should either remain the same or increase, and within experimental error (as
observed by the relatively high standard deviations observed) this trend was observed. .

Figure 15. Polymers cause negligible hemolysis (<10 %) up to 3000 μg/mL. The concentration
of polymer required to cause 50 % hemolysis (HC50) is reported as >3000 μg/mL to estimate
polymer selectivity.
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4.4 MTT Assay (Cell Viability)

MTT assays were performed to further investigate the eukaryotic cytotoxicity of the
homopolymers of APMA and GPMA and the statistical copolymer PGT 50. Figure 16 shows
cell viability as a function of polymer concentration after 6 and 12 hours for these polymers. In a
MTT assay, the conversion of MTT to purple formazan by mitochondrial reductase is utilized to
quantify the mitochondrial activity of the cells rather than directly visualizing the number of
living cells. Although the homopolymer of GPMA (PGT 100) caused negligible hemolysis, a
drastic reduction in MCF-7 cell viability was observed at high concentrations (>200 µg/mL).
However, this concentration is much higher than that required for antimicrobial effectiveness,
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Figure 16. Cell viability of MCF-7 cells after incubation with polymers PAPMA (bottom left),
PGT 50 (top), and PGT 100 (bottom right) for 6 and 12 hours.
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Chapter V: Conclusions

A series of well-defined primary amine-functionalized and guanidinium-functionalized
methacrylamide homopolymers and statistical copolymers were synthesized via aqueous RAFT
polymerization. These polymeric mimics of antimicrobial peptides were all shown to exhibit
excellent antimicrobial behavior (MICs of ~300 µg/mL or lower) for B. subtilis, S. aureus, and
E. coli. With B. subtilis and S. aureus, the MICs of the AMP mimics appeared to be the same for
all polymer types of the respective bacteria. However with E. coli, increasing the guanidinium
content greatly enhanced the antimicrobial efficiency of the polymer. Thus, the polymer
structure, such as the presence of a primary amine and/or guanidinium moiety, appears to play a
crucial role in its antimicrobial activity.
As shown in the biocompatibility studies (hemolysis experiments and MTT assays),
these AMP mimics were shown to be selective for bacterial cells within the respective
therapeutic range. However, the homopolymer of GPMA (PGT 100) was shown to drastically
reduce cell viability at relativity high concentrations (>200 µg/mL). This trend, which did not
appear in the cell viability trends of PAPMA or PGT 50, is most likely the result of a change in
the mechanism of activity. Copolymers with high concentrations of guanidinium have been
previously shown to follow a primarily membrane permeation mechanism, and this would
explain the increased antimicrobial behavior and decreased cell viability at high concentrations.22
At high concentrations of the guanidinium moiety, loss of selectivity may occur due to the
change in the mechanism of activity.
After several attempts to perform the large unilamellar vesicles (LUV) studies, the data
gathered was not consistent and will not be provided in this report. The delicate nature of the
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LUVs along with a high degree of experimental error yielded no reproducible data. Because
negligible hemolysis was observed for all polymer compositions, it is concluded that the cell
permeation mechanism was the dominant mode of antimicrobial activity for the polymers tested.
Further investigation, including LUV experiments, is needed to substantiate this claim.

Chapter VI: Future Work

Antimicrobial peptide (AMP) mimics have been shown to be a promising alternative for
conventional antibiotics against antibiotic-resistant microbes. It is recommended that LUV
studies be performed with the antimicrobial peptide mimics described in this study. Elucidating
the mechanism of action of these polymers will help to provide a better understanding of the
structure-activity relationships present in these compounds. Once a suggested mechanism of
action is proposed from the LUV studies, transmission electron microscopy imaging should be
performed to further validate the proposed mechanism of action. This knowledge will be
beneficial in designing new antimicrobial peptide mimics to target specific antibiotic-resistant
bacteria in the future.
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